These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 760195)

  • 41. Radioligand and immunochemical studies of turtle oviduct progesterone and estrogen receptors: correlations with hormone treatment and oviduct contractility.
    Giannoukos G; Callard IP
    Gen Comp Endocrinol; 1996 Jan; 101(1):63-75. PubMed ID: 8713645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of estrogen-binding proteins in variants of a rat mammary tumor.
    Scala DA; Ip MM
    Cancer Res; 1987 Aug; 47(16):4287-92. PubMed ID: 3607763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 44. Nuclear estradiol and cytosol progestin receptor concentrations in the brain and the pituitary gland and sexual behavior in ovariectomized estradiol-treated middle-aged rats.
    Wise PM; Parsons B
    Endocrinology; 1984 Aug; 115(2):810-6. PubMed ID: 6745182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
    Merkulova TI; Morozova TM; Sakganik RI
    Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo enhancement of progesterone binding to the uterine progesterone receptor by cortisol.
    Saiduddin S; Zassenhaus HP
    Biochemistry; 1977 Jun; 16(13):2829-34. PubMed ID: 880282
    [No Abstract]   [Full Text] [Related]  

  • 47. Tamoxifen tolerance and steroid receptors in a tumor model.
    Kellen JA; Sutherland DJ
    In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of photooxidation on the estrogen receptor from rat mammary tumor.
    Feldman M; Kallos J; Hollander VP
    J Biol Chem; 1980 Sep; 255(18):8776-9. PubMed ID: 7410393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An ovarian independent population of uterine estrogen receptors.
    Quarmby VE; Korach KS
    Life Sci; 1983 Sep; 33(12):1205-11. PubMed ID: 6888174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.
    Lewko WM; Wittliff JL
    J Toxicol Environ Health; 1983 Jul; 12(1):127-41. PubMed ID: 6632000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progesterone and progesterone receptors in experimental breast cancer.
    Horwitz KB; McGuire WL
    Cancer Res; 1977 Jun; 37(6):1733-8. PubMed ID: 404036
    [No Abstract]   [Full Text] [Related]  

  • 53. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ; Giladi M; Khan S; Hollander VP
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Arafah BM; Manni A; Pearson OH
    Endocrinology; 1980 Nov; 107(5):1364-9. PubMed ID: 6253265
    [No Abstract]   [Full Text] [Related]  

  • 56. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors.
    Kelly PA; Asselin J; Turcot-Lemay L; Labrie F; Raynaud JP
    Eur J Cancer (1965); 1979 Oct; 15(10):1243-51. PubMed ID: 230056
    [No Abstract]   [Full Text] [Related]  

  • 59. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel.
    Wrange O; Nordenskjöld B; Gustafsson JA
    Anal Biochem; 1978 Apr; 85(2):461-75. PubMed ID: 565601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.